C. Murano, A. Igarashi, K. Yamauchi, S. Inoue, and M. Watanabe, “Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma”, EXCLI J., vol. 18, pp. 893–898, Oct. 2019.